報價延遲最少15分鐘:2025/11/05 07:53 EST
盤前時段
|
||||
|
-- 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
13.74
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.49/-1.74
|
|
企業價值
1.45B
|
| 資產負債 |
|
每股賬面淨值
1.57
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
87.37M
|
|
每股收益
1.80
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/11/05 07:53 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions. |
